Immunizing Older Individuals Requires Flexibility, Nuance
Pharmacy Times
JANUARY 2, 2023
When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.
Pharmacy Times
JANUARY 2, 2023
When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.
Pharma Phorum
JULY 5, 2021
Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. While these numbers do tell us something about the relative immunity of the population writ large, they don’t tell us anything about our own, personal immune profiles.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 5, 2022
The panel of pharmacists discuss the immunization tracker registry and emphasize utilizing this tool in preparation for the coming flu season.
European Pharmaceutical Review
MARCH 6, 2023
Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection.
Pharma Phorum
FEBRUARY 11, 2021
Shares in Swiss biotech AC Immune have risen sharply after it said a vaccine in development for Alzheimer’s disease (AD) hit the mark in a phase 1/2 trial. . AC Immune’s previous attempts to target tau in AD haven’t gone according to plan.
European Pharmaceutical Review
OCTOBER 20, 2022
Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?mediated
Pharmacy Times
NOVEMBER 17, 2022
Importance of clear and accurate documentation is emphasized in patient claim for compensation.
Pharmacy Times
JULY 11, 2022
There is new guidance needed for pediatric immunizations, and pharmacists should be prepared for what's to come.
Fierce Healthcare
DECEMBER 7, 2022
Not Just for Kids: The Case for Modernizing Immunization Registries. mteefey. Wed, 12/07/2022 - 16:20
Pharmacy Times
SEPTEMBER 16, 2022
Corticosteroids are first-line therapy for gaining platelet stability but should only be used short term.
Pharmacy Times
AUGUST 23, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.
Pharmacy Times
JULY 22, 2022
Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.
Pharmacy Times
AUGUST 12, 2022
Pharmacists discuss barriers contributing to vaccine reluctance among young adults, including varying degrees of education, accessibility, and convenience.
Pharma Phorum
AUGUST 2, 2022
In May, another amyloid targeting drug for Alzheimer’s disease – AC Immune and Roche’s crenezumab – missed the mark in another clinical trial and looked destined for the scrap heap like so many drugs in the class before it.
Pharma Phorum
MARCH 15, 2021
MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us.
Pharmacy Times
JULY 29, 2022
Pharmacists highlight patient hesitations surrounding vaccinations and offer a multitude of approaches for alleviating these concerns.
Pharmacy Times
JANUARY 9, 2023
Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.
Pharmacy Times
JANUARY 5, 2023
The protein, called suPAR, has long been known to be a biomarker for poor outcomes and disease progression in both kidney disease and cardiovascular disease.
Pharma Phorum
JULY 26, 2021
“Being able to distinguish the IgM from the IgG class of antibody response will also provide potentially useful information about the stage of a person’s immune response, and its likely persistence over time,” he added.
Pharmacy Times
AUGUST 26, 2022
Wellblends Immune & Respiratory is a 3-in-1 blend designed with ingredients to provide advanced immune support.
Pharmacy Times
OCTOBER 4, 2022
As pharmacy moves in the direction of patient-centered care, immunization plays a key role in this shift.
Pharma Phorum
DECEMBER 4, 2020
The 4 th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on.
Fierce Healthcare
OCTOBER 20, 2022
CDC advisory panel recommends adding COVID vaccine to kids' routine immunization schedule. fdiamond. Thu, 10/20/2022 - 08:23
Pharmacy Times
OCTOBER 28, 2022
Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.
Pharmacy Times
OCTOBER 26, 2022
In a panel, pharmacy technicians across the world discuss what immunizations and point-of-care testing looks like in United States, Portugal, and the United Kingdom.
Pharma Phorum
DECEMBER 17, 2021
The Sacklers said earlier they would exit the settlement deal if they were not granted immunity, and the judge in the bankruptcy court that accepted the deal – Robert Drain – said he did not want to jeopardise what was on offer by seeking further changes.
Pharmacy Times
DECEMBER 21, 2022
Pharmacists and student pharmacists became the center of responding to the Monkeypox outbreak by providing immunizations to their communities.
Pharmacy Times
OCTOBER 25, 2022
People with anxiety and related disorders were found to have vaccine hesitancy related to concerns regarding adverse effects and efficacy.
Pharmacy Times
DECEMBER 6, 2022
Novel mutations in the gene GTF3A impairs the innate immune response to herpes simplex virus 1.
Pharmacy Times
AUGUST 9, 2022
The ability of an anti-interleukin-23 antibody to bind to key immune system components may help neutralize a key driver of inflammation right at its cellular source.
Pharmacy Times
JANUARY 4, 2023
Judy Neville speaks with pharmacy technicians about the impact of pharmacy technician as vaccinators.
Pharma Phorum
NOVEMBER 4, 2021
That allows the immune system to see the transplanted organ as self rather than foreign. The post Talaris therapy ends need for immune drugs in transplant patients appeared first on.
Pharma Phorum
SEPTEMBER 23, 2020
Shares in AC Immune have collapsed after partner Genentech revealed its tau-targeting Alzheimer’s drug semorinemab had flunked a phase 2 trial in Alzheimer’s disease (AD). The post AC Immune poleaxed on Alzheimer’s study fail appeared first on.
Pharmacy Times
JULY 27, 2022
Study findings coincide with the US government considering recommendations of a second COVID-19 booster dose for adults under 50 years of age.
Pharmacy Times
AUGUST 3, 2022
Increasing population immunity decreased transmission of COVID-19 and allowed for reductions in quarantine and testing, encouraging 2-dose vaccine and booster uptake.
Fierce Pharma
DECEMBER 10, 2022
ASH: With immune thrombocytopenia win, argenx proves efgartigimod’s no one-trick pony in autoimmune disease. fkansteiner. Sat, 12/10/2022 - 09:12
Pharma Phorum
SEPTEMBER 2, 2021
A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of contributing to opioid epidemic – to the consternation of campaigners.
Pharmacy Times
MARCH 23, 2023
Among patients with lung cancer, approximately 20% have the earliest stage of disease but are still dying of metastatic lung cancer within about 5 years.
Pharmacy Times
AUGUST 19, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, discussed how mRNA vaccines could change the treatment landscape for respiratory illnesses.
Pharma Phorum
AUGUST 20, 2021
Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part of their $1.2 The post BMS buys into AI-designed immune drug from Exscientia appeared first on.
Pharmacy Times
DECEMBER 11, 2022
Expert discusses the results of a trial assessing immune reconstitution in adult patients who received Orca-T, consisting of hematopoietic stem/progenitor cells, regulatory T cells, and conventional T cells.
Outsourcing Pharma
DECEMBER 21, 2020
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
Pharmacy Times
JULY 20, 2022
Hyqvia is an immune globulin with a recombinant human hyaluronidase indicated for the treatment of primary immunodeficiency in adults.
Let's personalize your content